Clinical Trials Logo
  1. Home
  2. Tricuspid Valve Regurgitation
  3. NCT05767645

Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study — TRIBUTE  

Tricuspid Valve Regurgitation Clinical Trial

Official title:
Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study

Clinical Trial Summary

The Mistral is an investigational device intended for percutaneous trans-catheter repair in high risk for surgery individuals suffering from functional Tricuspid Regurgitation (TR). The device system is to be used only in accordance with the approved Investigational Plan on subjects who have signed an informed consent form. Device use is limited to the approved study investigators.

Clinical Trial Description

The main objectives of this study are to evaluate safety and effectiveness of the Mistral implant for the percutaneous treatment of patients with symptomatic moderate or greater tricuspid regurgitation (TR) who are at high risk for tricuspid valve surgery. Primary endpoints: - Safety: Incidence of Major Device Related Adverse Events (MDRAE). [Time frame: 6 months]. - Efficacy: Echocardiographic improvement in TR severity of at least 1 grade [Time Frame: 30 days]. Secondary endpoints: Safety: - Incidence of Major Device Related Adverse Events (MDRAE). [Time Frame: 1, 6, 12, and 24 months]. - Incidence of device or procedure related serious adverse events [Time Frame: 30 days]. Efficacy: • Change in TR grade by Echocardiography [Time Frame: 1, 6, 12, and 24 months over baseline]. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05767645
Study type Interventional
Source Mitralix
Contact Dana Yaron
Phone +972542330022
Email dana@mitralix.com
Status Recruiting
Phase N/A
Start date June 21, 2021
Completion date September 1, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT01246947 - Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation N/A
Recruiting NCT04577248 - The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Completed NCT02787408 - The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System N/A
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A
Active, not recruiting NCT04221490 - 2019-06 TRISCEND Study N/A
Completed NCT01585779 - Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial N/A
Recruiting NCT05194423 - THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein N/A
Completed NCT01246141 - The Comparison of Tricuspid Replacement and Repair in Patients With Combined Heart Valve Disease N/A
Withdrawn NCT03928639 - Structural Heart and Valve Network PROSPECTIVE Registry
Not yet recruiting NCT05577078 - TriBEL Registry: National Belgian Registry of Percutaneous Tricuspid Valve Repair Using a Transcatheter Edge-to-edge Repair Technique
Recruiting NCT05760989 - TRISCEND JAPAN Study N/A
Completed NCT02471807 - Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System N/A
Completed NCT04071652 - MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study N/A
Active, not recruiting NCT04483089 - An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated With the Abbott TriClip™ Device (bRIGHT)
Not yet recruiting NCT05936125 - Short Term Outcomes Of Tricuspid Valve Annuloplasty Using A Flexible Band N/A
Recruiting NCT04482062 - TRISCEND II Pivotal Trial N/A
Completed NCT04073979 - MATTERS II - Mistral Percutaneous Tricuspid Valve Repair FIM Study N/A